Literature DB >> 27959719

Acute Myeloid Leukemia - Many Diseases, Many Treatments.

Elihu Estey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27959719     DOI： 10.1056/NEJMe1611424

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.

Authors:  Maximilian Stahl; Michelle DeVeaux; Pau Montesinos; Raphael Itzykson; Ellen K Ritchie; Mikkael A Sekeres; John D Barnard; Nikolai A Podoltsev; Andrew M Brunner; Rami S Komrokji; Vijaya R Bhatt; Aref Al-Kali; Thomas Cluzeau; Valeria Santini; Amir T Fathi; Gail J Roboz; Pierre Fenaux; Mark R Litzow; Sarah Perreault; Tae Kon Kim; Thomas Prebet; Norbert Vey; Vivek Verma; Ulrich Germing; Juan Miguel Bergua; Josefina Serrano; Steven D Gore; Amer M Zeidan
Journal:  Blood Adv       Date:  2018-04-24

2.  Topoisomerase Assays.

Authors:  John L Nitiss; Kostantin Kiianitsa; Yilun Sun; Karin C Nitiss; Nancy Maizels
Journal:  Curr Protoc       Date:  2021-10

3.  Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML.

Authors:  Mohamed L Sorror; Shirali Agarwal; Megan Othus; Ylinne Lynch; Jennifer E Nyland; Mary-Elizabeth Percival; Pamela S Becker; Frederick R Appelbaum; Elihu H Estey
Journal:  Cancer Med       Date:  2020-07-24       Impact factor: 4.452

4.  Identification of MiR-93-5p Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation.

Authors:  Jie Wang; Yun Wu; Md Nazim Uddin; Jian-Ping Hao; Rong Chen; Dai-Qin Xiong; Nan Ding; Jian-Hua Yang; Jian-Hua Wang; Xuan-Sheng Ding
Journal:  J Oncol       Date:  2021-03-19       Impact factor: 4.375

5.  Role and Mechanism of lncRNA-pvt1 in the Pathogenesis of Acute Lymphoblastic Leukemia in Children.

Authors:  Yanli Cheng; Guoping Hao; Xiaohuan Wang; Haiyan Lu; Jing Wang; Taoli Suo; Zhaohui Hou; Huimin Guo; Shixun Zhang
Journal:  Comput Math Methods Med       Date:  2022-03-04       Impact factor: 2.238

6.  Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.

Authors:  Jie Wang; Jian-Ping Hao; Md Nazim Uddin; Yun Wu; Rong Chen; Dong-Feng Li; Dai-Qin Xiong; Nan Ding; Jian-Hua Yang; Xuan-Sheng Ding
Journal:  Aging (Albany NY)       Date:  2021-06-18       Impact factor: 5.682

7.  Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations.

Authors:  Limin Li; Xiaoqian Zhang; Hongjuan Yu; Mingwen Zhang; Mengyuan Xu; Jie Liu; Yueyue Fu; Hongbin Meng; Chengfang Lyu; Xiaoxia Li; Jin Zhou
Journal:  Onco Targets Ther       Date:  2018-10-12       Impact factor: 4.147

8.  Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia.

Authors:  Wei Liu; Feiyue Zhu; Jiazhuo Yan; Yi Liu; Cong Chen; Kaixuan Zhang; Xielan Zhao; Jingyuan Chen
Journal:  Onco Targets Ther       Date:  2020-11-02       Impact factor: 4.147

9.  Intensive patient's care program reduces anxiety and depression as well as improves overall survival in de novo acute myelocytic leukemia patients who underwent chemotherapy: a randomized, controlled study.

Authors:  Hongxia Bao; Yalin Chen; Min Li; Longrui Pan; Xuena Zheng
Journal:  Transl Cancer Res       Date:  2019-02       Impact factor: 1.241

10.  Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.

Authors:  Mohamed L Sorror; Barry E Storer; Amir T Fathi; Andrew Brunner; Aaron T Gerds; Mikkael A Sekeres; Sudipto Mukherjee; Bruno C Medeiros; Eunice S Wang; Pankit Vachhani; Paul J Shami; Esteban Peña; Mahmoud Elsawy; Kehinde Adekola; Selina Luger; Maria R Baer; David Rizzieri; Tanya M Wildes; Jamie Koprivnikar; Julie Smith; Mitchell Garrison; Kiarash Kojouri; Wendy Leisenring; Lynn Onstad; Jennifer E Nyland; Pamela S Becker; Jeannine S McCune; Stephanie J Lee; Brenda M Sandmaier; Frederick R Appelbaum; Elihu H Estey
Journal:  Blood       Date:  2021-08-05       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.